Research Purposes Only
This website contains information about research peptides intended strictly for laboratory and scientific research. You must be 18 years or older to enter.
By entering you confirm you are 18+ and agree that all products are for research use only. Not for human consumption.
Dual GIP/GLP-1 Receptor Agonist
Tirzepatide is a novel dual GIP/GLP-1 receptor agonist. Studied for its combined incretin effects on glucose metabolism, insulin sensitivity, and energy regulation in metabolic research settings.
Tirzepatide is a first-in-class dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is a 39-amino acid synthetic peptide based on the native GIP sequence with modifications that confer balanced agonism at both incretin receptors. In vitro research applications include dual incretin receptor pharmacology studies, comparative GIP vs. GLP-1 signaling pathway analysis, pancreatic islet cell function research, and investigations into the additive or synergistic metabolic effects of simultaneous GIP/GLP-1 receptor activation. Tirzepatide represents a valuable research tool for understanding the incretin axis in metabolic disease.
GLP-1 Receptor Agonist
Semaglutide is a long-acting GLP-1 (glucagon-like peptide-1) receptor agonist. Used extensively in metabolic and endocrine research to study insulin secretion, glucagon suppression, and energy homeostasis.
Nicotinamide Adenine Dinucleotide
NAD+ is a critical coenzyme found in all living cells, central to redox reactions and energy metabolism. Studied extensively for its roles in sirtuin activation, DNA repair, and cellular aging research.
Triple Receptor Agonist (GIP/GLP-1/Glucagon)
Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist. Studied for its combined triagonist effects on metabolic regulation, energy expenditure, and glucose homeostasis in laboratory research.
For Research Purposes Only · Not intended for human consumption